Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 2Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Melanoma 7Hodgkin Disease 7Neoplasm Metastasis 3Lymphoma 3Recurrence 2Neuroblastoma 2Neuroendocrine Tumors 1

Interventions

Cyclophosphamide 12Vincristine 10Radiotherapy 10Carboplatin 10Cisplatin 8Melphalan 7Etoposide 73-Iodobenzylguanidine 7Isotretinoin 6Filgrastim 6Doxorubicin 6aldesleukin 4Peripheral Blood Stem Cell Transplantation 4Busulfan 4etoposide phosphate 3Topotecan 3Neoadjuvant Therapy 3Interleukin-2 3Ifosfamide 3fludarabine 2dinutuximab 2Vindesine 2Polymerase Chain Reaction 2Granulocyte-Macrophage Colony-Stimulating Factor 2Dacarbazine 2Chemotherapy, Adjuvant 2sargramostim 1irinotecan sucrosofate 1ganglioside, GD2 1fludarabine phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Neuroblastoma × Dacarbazine × Clear all
NCT00526318 2015-07-16

Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma

National Cancer Institute (NCI)

Phase NA Unknown
360 enrolled
CNS

Neuroblastoma

NCT00410631 2013-08-07

Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma

National Cancer Institute (NCI)

Phase 3 Unknown
642 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡